Clinical trial
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients: A Randomized, Observer-Blinded, Prospective Clinical Trial
NCT04164173 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hyperinflation Respiratory Therapies in Cardiac Surgery Patients: A Randomized, Observer-Blinded, Prospective Clinical Trial
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 15, 2020
- Completion date
- December 31, 2028
- Enrollment
- 324 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative complications, pulmonary disease